Epidemiology of NSAID induced gastrointestinal complications.
about
S-adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: a double-blind cross-over trial. [ISRCTN36233495]Time dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approachImplications of analgesics use in osteoporotic-related pain treatment: focus on opioidsPrevalence of non-Helicobacter pylori duodenal ulcer in Karachi, PakistanAssociation between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studiesBalancing the gastrointestinal benefits and risks of nonselective NSAIDs.Contraindicated NSAIDs are frequently prescribed to elderly patients with peptic ulcer diseasePerception of the risk of adverse drug reactions: differences between health professionals and non health professionalsAssessment of non-steroidal anti-inflammatory drug (NSAID) damage in the human gastrointestinal tractAcetylsalicylic acid as an adjuvant therapy for schizophreniaO2-acetoxymethyl-protected diazeniumdiolate-based NSAIDs (NONO-NSAIDs): synthesis, nitric oxide release, and biological evaluation studiesAn economic model of long-term use of celecoxib in patients with osteoarthritisNonsteroidal Anti-Inflammatory Drugs and the KidneyThe use of H2 antagonists in treating and preventing NSAID-induced mucosal damage.A 6-week, multicentre, randomised, double-blind, double-dummy, active-controlled, clinical safety study of lumiracoxib and rofecoxib in osteoarthritis patients.Mechanisms of Kv2.1 channel inhibition by celecoxib--modification of gating and channel blockMast cells are critical for protection against peptic ulcers induced by the NSAID piroxicam.A comparative study of DA-9601 and misoprostol for prevention of NSAID-associated gastroduodenal injury in patients undergoing chronic NSAID treatmentCharacteristics and clinical outcome of nonsteroidal anti-inflammatory drug-induced acute hepato-nephrotoxicity among Chinese patientsThree decades of research on computer applications in health care: medical informatics support at the Agency for Healthcare Research and Quality.The novel phospho-non-steroidal anti-inflammatory drugs, OXT-328, MDC-22 and MDC-917, inhibit adjuvant-induced arthritis in rats.Prescription pattern of NSAIDs and the prevalence of NSAID-induced gastrointestinal risk factors of orthopaedic patients in clinical practice in Korea.Clinical evidence of interaction between clopidogrel and proton pump inhibitorsOne decade follow up after nucleoplasty in the management of degenerative disc disease causing low back pain and radiculopathyBritish Journal of Clinical Pharmacology review series. Clinical research methods in gastroenterology.Incidence of clinically manifest ulcers and their complications in patients with rheumatoid arthritisA randomised, placebo controlled, comparative trial of the gastrointestinal safety and efficacy of AZD3582 versus naproxen in osteoarthritisCarboxylesterases 1 and 2 hydrolyze phospho-nonsteroidal anti-inflammatory drugs: relevance to their pharmacological activity.Comparison of the pharmacokinetics and tolerability of HCP1004 (a fixed-dose combination of naproxen and esomeprazole strontium) and VIMOVO® (a marketed fixed-dose combination of naproxen and esomeprazole magnesium) in healthy volunteers.Prescription of and adherence to non-steroidal anti-inflammatory drugs and gastroprotective agents in at-risk gastrointestinal patientsIncreased Risk of End-Stage Renal Disease (ESRD) Requiring Chronic Dialysis is Associated With Use of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Nationwide Case-Crossover Study.Effects of nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NONO-NSAIDs) on melanoma cell adhesion.Patient's Knowledge and Perception Towards the use of Non-steroidal Anti-Inflammatory Drugs in Rheumatology Clinic Northern Malaysia.Italian survey on non-steroidal anti-inflammatory drugs and gastrointestinal bleeding in children.Positional isomers of aspirin are equally potent in inhibiting colon cancer cell growth: differences in mode of cyclooxygenase inhibition.Implementation and evaluation of adverse drug reaction monitoring system in a tertiary care teaching hospital in Mumbai, IndiaCombination therapy versus celecoxib, a single selective COX-2 agent, to reduce gastrointestinal toxicity in arthritic patients: patient and cost-effectiveness considerations.Modulation of carcinogen metabolism by nitric oxide-aspirin 2 is associated with suppression of DNA damage and DNA adduct formation.Elderly patients' experiences using adaptive conjoint analysis software as a decision aid for osteoarthritis of the knee.Nonsteroidal Anti-Inflammatory Drug-Induced Gastroduodenal Bleeding: Risk Factors and Prevention Strategies.
P2860
Q21093296-40F6359F-71BB-4B75-9C77-907B8E0C612BQ24673561-4BA8FA2D-8669-40B8-8481-9889FDF5E48BQ28071550-78B36AC6-6B38-4CC1-9B84-BF2E0EDB96FDQ28180899-99BE3A44-4C70-4974-8493-EF55DA914863Q28191843-A9E2A1CB-8260-4506-92DC-AE6CC84B4D20Q28191932-5A7F4502-8838-4BDC-8E3D-7D46207B0759Q28192384-47357DD6-F8D6-4949-8462-1E9726C6EB75Q28194005-9A9D92E1-FA4B-4189-8803-1FBCFF9D5F8DQ28196933-31E3B7EA-8AC6-4247-BA82-28336357B60FQ28200931-D2403995-FEAA-440E-AB43-9BE454870AFDQ28210989-43C13A68-0D65-42FE-A7D4-990E720B32F1Q28218005-A944E870-2783-4ADB-818B-210D94016E6CQ28386844-E8E072D2-71B7-440D-9E99-B0A677D82EA7Q30415171-7E48F30B-7147-4D88-9ED6-DA6199F215CAQ33367787-BD15D629-485F-4D45-A927-CA708EDA8051Q33673130-BDFCA5F0-1383-485A-BE41-C310E84EE713Q33999952-408929E9-F868-4281-A519-93316E8F7DB8Q34250591-B9080E1B-72A1-4515-B301-8E28E79DFF53Q34326687-B86A8897-B095-4767-80CF-63E9246F0952Q34542312-63ACB7C0-E959-4DA0-963F-77A962DB7799Q34672072-AC062DAF-B10C-4F92-A0B7-8E1A04F02F48Q34753461-11B05C0E-BCAB-4299-B45D-B1F9496BA55CQ35033722-EB6208C3-5D8B-4699-A6AF-86A0B0539BFDQ35156509-0F06FD71-0378-4A85-B227-C107E714A21BQ35190646-F638AECA-BA22-4C4F-AA66-C1835776093CQ35550442-0E6178CC-6C31-4E2D-B72D-3D72DE6BB9F0Q35555299-E4566608-F320-4BF7-B832-5E71F5A6682CQ35688543-02C6F610-E378-4C4D-A5B7-0134C36168A3Q35923793-BBE0BD3D-A364-47B5-B9C8-9ADFA3177469Q36011124-788DCED8-0EEE-46ED-B750-A4448F89DA49Q36255870-6DC9AF94-087B-4D1D-9EAD-700A24BF3791Q36291456-D738EA19-5D77-44AC-A862-A33D2F72F18CQ36447439-ECB98B4F-E886-40E8-8276-8F3019D209B2Q36495357-B3C370DE-21F4-4A80-B79F-61DC890A5B8DQ36717145-99FD055E-4016-49D6-99BF-E6433F569D86Q37226353-3D8A1822-DBEA-4B3A-A5BE-49FDF66C8446Q37358250-39FBF8BA-7DFA-4090-99C8-C1A47E8365ACQ37372211-C4A8376D-95C5-4BA1-8970-14AE0371912DQ37446207-B9179229-D39C-481B-9701-C742E3CAD7A1Q38974392-12B989BE-CF47-40C9-BD03-1FA36175C969
P2860
Epidemiology of NSAID induced gastrointestinal complications.
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Epidemiology of NSAID induced gastrointestinal complications.
@ast
Epidemiology of NSAID induced gastrointestinal complications.
@en
type
label
Epidemiology of NSAID induced gastrointestinal complications.
@ast
Epidemiology of NSAID induced gastrointestinal complications.
@en
prefLabel
Epidemiology of NSAID induced gastrointestinal complications.
@ast
Epidemiology of NSAID induced gastrointestinal complications.
@en
P1476
Epidemiology of NSAID induced gastrointestinal complications
@en
P2093
Triadafilopoulos G
P577
1999-04-01T00:00:00Z